Wells Fargo’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.27M Sell
16,547
-588
-3% -$80.8K ﹤0.01% 2836
2025
Q1
$3.09M Buy
17,135
+207
+1% +$37.3K ﹤0.01% 2480
2024
Q4
$2.65M Buy
16,928
+2,972
+21% +$466K ﹤0.01% 2612
2024
Q3
$2.54M Sell
13,956
-534
-4% -$97.2K ﹤0.01% 2589
2024
Q2
$2.66M Buy
14,490
+5,332
+58% +$979K ﹤0.01% 2507
2024
Q1
$1.63M Buy
9,158
+1,598
+21% +$284K ﹤0.01% 2837
2023
Q4
$938K Sell
7,560
-12,433
-62% -$1.54M ﹤0.01% 3146
2023
Q3
$2.32M Sell
19,993
-1,720
-8% -$200K ﹤0.01% 2505
2023
Q2
$2.55M Buy
21,713
+3,528
+19% +$414K ﹤0.01% 2564
2023
Q1
$1.46M Buy
18,185
+13,915
+326% +$1.11M ﹤0.01% 2930
2022
Q4
$338K Sell
4,270
-647
-13% -$51.3K ﹤0.01% 3639
2022
Q3
$343K Sell
4,917
-386
-7% -$26.9K ﹤0.01% 3670
2022
Q2
$348K Sell
5,303
-4,317
-45% -$283K ﹤0.01% 3734
2022
Q1
$640K Sell
9,620
-5,345
-36% -$356K ﹤0.01% 3975
2021
Q4
$1.05M Buy
14,965
+9,288
+164% +$650K ﹤0.01% 3808
2021
Q3
$296K Buy
5,677
+5,472
+2,669% +$285K ﹤0.01% 4663
2021
Q2
$14K Sell
205
-1,489
-88% -$102K ﹤0.01% 5703
2021
Q1
$130K Sell
1,694
-12,280
-88% -$942K ﹤0.01% 5036
2020
Q4
$839K Sell
13,974
-11,337
-45% -$681K ﹤0.01% 4094
2020
Q3
$1.09M Sell
25,311
-175,211
-87% -$7.55M ﹤0.01% 3712
2020
Q2
$8.31M Buy
200,522
+68,105
+51% +$2.82M ﹤0.01% 1992
2020
Q1
$5.73M Buy
132,417
+88,438
+201% +$3.82M ﹤0.01% 2095
2019
Q4
$2.44M Buy
43,979
+27,422
+166% +$1.52M ﹤0.01% 3163
2019
Q3
$575K Buy
16,557
+7,102
+75% +$247K ﹤0.01% 4171
2019
Q2
$381K Buy
9,455
+280
+3% +$11.3K ﹤0.01% 4436
2019
Q1
$302K Buy
9,175
+245
+3% +$8.06K ﹤0.01% 4553
2018
Q4
$185K Buy
8,930
+8,630
+2,877% +$179K ﹤0.01% 4767
2018
Q3
$5K Hold
300
﹤0.01% 5698
2018
Q2
$4K Buy
+300
New +$4K ﹤0.01% 5725